These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


68 related items for PubMed ID: 6477184

  • 21. Dependence of the cardiovascular effects of pindolol on the individual sympathetic nervous activity.
    Tanaka N, Kawahira K, Kudo A, Kashima T, Tanaka H.
    Eur J Clin Pharmacol; 1982; 22(5):383-7. PubMed ID: 6288395
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. A comparative study on the effects of pindolol and propranolol on systemic and cardiac haemodynamics in hypertensive patients.
    Velasco M, Morillo J, Ramirez A, Hernández E, Vizcarrondo H, Urbin-Aquintana A, López JM, Medrano G, Hernández-Pieretti O.
    Int J Clin Pharmacol Res; 1983; 3(2):95-100. PubMed ID: 6384072
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Ventricular function in mitral valve prolapse: effects of beta adrenergic blockers with and without intrinsic sympathomimetic activity].
    Marin-Neto JA, Mattar Júnior L, Maciel BC, Gallo Júnior L, Iazigi N, Ferro D.
    Arq Bras Cardiol; 1989 May; 52(5):247-52. PubMed ID: 2690783
    [Abstract] [Full Text] [Related]

  • 29. Sympathomimetic and cardiodepressant effects of acebutolol, oxprenolol, pindolol, and propranolol. A comparative study on changes in hemodynamics, contractility, heart rate, and AV-conduction time at therapeutic doses.
    Gülker H, Kristek J, Heuer H, Bender F.
    Arzneimittelforschung; 1981 May; 31(9):1416-22. PubMed ID: 6118162
    [Abstract] [Full Text] [Related]

  • 30. [Changes in hemodynamics under the effect of two beta sympathicolytics of various pharmacodynamic principle].
    Lang E, Holtmann W.
    Arzneimittelforschung; 1974 Sep; 24(9):1330-5. PubMed ID: 4479799
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Evaluation of the effect of Isoptin-Retard on central hemodynamics and parameters of diastolic ventricular function in patients with hypertension].
    Glotov MN, Pshenitsin AI, Mazur NA, Malov AG.
    Ter Arkh; 1993 Sep; 65(9):29-32. PubMed ID: 8303589
    [Abstract] [Full Text] [Related]

  • 34. Effects of four antihypertensive monotherapies on cardiac mass and function in hypertensive patients with left ventricular hypertrophy: randomized prospective study.
    Rakić D, Rumboldt Z, Bagatin J, Polić S.
    Croat Med J; 2002 Dec; 43(6):672-9. PubMed ID: 12476475
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Human pharmacology of carteolol].
    Lorenz D.
    Arzneimittelforschung; 1983 Dec; 33(2a):296-304. PubMed ID: 6682321
    [No Abstract] [Full Text] [Related]

  • 37. Beta blockade and intermittent claudication.
    Lepäntalo M.
    Acta Med Scand Suppl; 1985 Dec; 700():1-48. PubMed ID: 2865873
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Treatment of essential hypertension with pindolol].
    Kocemba J, Kawecka-Jaszcz K, Sniezek M, Starzycka M, Augustyński W.
    Kardiol Pol; 1978 Dec; 21(3):201-8. PubMed ID: 691928
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 4.